data_6q8l_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6q8l _Structure_validation_residue.Date_analyzed 2020-01-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.57 2.317 0 N-CA-C 115.519 1.315 . . . . 0.0 115.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.573 2.445 0 N-CA-C 116.512 1.697 . . . . 0.0 116.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo . . . . . 0 CA--C 1.572 2.381 0 N-CA-C 115.417 1.276 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 CA--C 1.571 2.349 0 N-CA-C 115.846 1.441 . . . . 0.0 115.846 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.569 2.257 0 N-CA-C 115.549 1.326 . . . . 0.0 115.549 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.569 2.253 0 N-CA-C 116.084 1.532 . . . . 0.0 116.084 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 115.844 1.44 . . . . 0.0 115.844 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo . . . . . 0 CA--C 1.572 2.418 0 N-CA-C 116.068 1.526 . . . . 0.0 116.068 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 CA--C 1.571 2.327 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 N-CA-C 115.644 1.363 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -135.61 90.88 18.99 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.99 -31.93 29.52 Favored 'Trans proline' 0 CA--C 1.57 2.317 0 C-N-CA 122.194 1.929 . . . . 0.0 115.519 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -126.88 -75.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 O-C-N 117.082 -3.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.105 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -116.93 146.91 38.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.41 -28.91 46.02 Favored 'Trans proline' 0 CA--C 1.573 2.445 0 C-N-CA 122.014 1.81 . . . . 0.0 116.512 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -124.93 -74.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 O-C-N 116.407 -3.933 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -112.87 93.64 25.5 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.84 -30.24 22.22 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 CA-C-N 122.566 1.952 . . . . 0.0 115.417 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.78 -75.47 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 O-C-N 117.179 -3.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 152.99 59.7 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -64.53 -33.07 57.96 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 122.134 1.889 . . . . 0.0 115.846 169.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.34 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.527 0 O-C-N 117.094 -3.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.018 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.26 58.03 15.36 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.33 -29.07 32.43 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 122.276 1.984 . . . . 0.0 115.549 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.01 -75.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 117.084 -3.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -112.29 145.64 33.27 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.09 -31.1 46.32 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.104 1.869 . . . . 0.0 116.084 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.78 -74.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 117.108 -3.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.013 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -126.83 144.72 51.07 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 123.757 0.661 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.77 -32.08 47.35 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.05 1.833 . . . . 0.0 115.844 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 -75.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.572 0 O-C-N 117.003 -3.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.61 156.01 38.68 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -65.39 -30.81 53.07 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.276 1.984 . . . . 0.0 116.068 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.35 -75.54 0.58 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.113 -3.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 72.21 81.99 Favored Pre-proline 0 CA--C 1.569 1.688 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 -30.16 25.78 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.292 1.994 . . . . 0.0 115.565 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.58 -75.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.059 -3.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -137.27 80.24 34.59 Favored Pre-proline 0 CA--C 1.567 1.621 0 O-C-N 124.012 0.82 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.78 -29.51 23.64 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.444 2.096 . . . . 0.0 115.644 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.33 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 117.07 -3.519 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.57 2.317 0 N-CA-C 115.519 1.315 . . . . 0.0 115.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.573 2.445 0 N-CA-C 116.512 1.697 . . . . 0.0 116.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo . . . . . 0 CA--C 1.572 2.381 0 N-CA-C 115.417 1.276 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 3' ' ' LEU . 87.2 Cg_endo . . . . . 0 CA--C 1.571 2.349 0 N-CA-C 115.846 1.441 . . . . 0.0 115.846 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 2' ' ' PRO . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.569 2.257 0 N-CA-C 115.549 1.326 . . . . 0.0 115.549 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.569 2.253 0 N-CA-C 116.084 1.532 . . . . 0.0 116.084 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 115.844 1.44 . . . . 0.0 115.844 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 3' ' ' LEU . 67.8 Cg_endo . . . . . 0 CA--C 1.572 2.418 0 N-CA-C 116.068 1.526 . . . . 0.0 116.068 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 2' ' ' PRO . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 CA--C 1.571 2.327 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 N-CA-C 115.644 1.363 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -135.61 90.88 18.99 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.99 -31.93 29.52 Favored 'Trans proline' 0 CA--C 1.57 2.317 0 C-N-CA 122.194 1.929 . . . . 0.0 115.519 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -126.88 -75.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 O-C-N 117.082 -3.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.105 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -116.93 146.91 38.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.41 -28.91 46.02 Favored 'Trans proline' 0 CA--C 1.573 2.445 0 C-N-CA 122.014 1.81 . . . . 0.0 116.512 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -124.93 -74.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 O-C-N 116.407 -3.933 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -112.87 93.64 25.5 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.84 -30.24 22.22 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 CA-C-N 122.566 1.952 . . . . 0.0 115.417 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.78 -75.47 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 O-C-N 117.179 -3.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 152.99 59.7 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 3' ' ' LEU . 87.2 Cg_endo -64.53 -33.07 57.96 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 122.134 1.889 . . . . 0.0 115.846 169.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 2' ' ' PRO . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.34 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.527 0 O-C-N 117.094 -3.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.018 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.26 58.03 15.36 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.33 -29.07 32.43 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 122.276 1.984 . . . . 0.0 115.549 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.01 -75.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 117.084 -3.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -112.29 145.64 33.27 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.09 -31.1 46.32 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.104 1.869 . . . . 0.0 116.084 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.78 -74.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 117.108 -3.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.013 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -126.83 144.72 51.07 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 123.757 0.661 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.77 -32.08 47.35 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.05 1.833 . . . . 0.0 115.844 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 -75.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.572 0 O-C-N 117.003 -3.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.61 156.01 38.68 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 3' ' ' LEU . 67.8 Cg_endo -65.39 -30.81 53.07 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.276 1.984 . . . . 0.0 116.068 166.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 2' ' ' PRO . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.35 -75.54 0.58 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.113 -3.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 72.21 81.99 Favored Pre-proline 0 CA--C 1.569 1.688 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 -30.16 25.78 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.292 1.994 . . . . 0.0 115.565 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.58 -75.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.059 -3.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -137.27 80.24 34.59 Favored Pre-proline 0 CA--C 1.567 1.621 0 O-C-N 124.012 0.82 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.78 -29.51 23.64 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.444 2.096 . . . . 0.0 115.644 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.33 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 117.07 -3.519 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.57 2.317 0 N-CA-C 115.519 1.315 . . . . 0.0 115.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.573 2.445 0 N-CA-C 116.512 1.697 . . . . 0.0 116.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo . . . . . 0 CA--C 1.572 2.381 0 N-CA-C 115.417 1.276 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 3' ' ' LEU . 87.2 Cg_endo . . . . . 0 CA--C 1.571 2.349 0 N-CA-C 115.846 1.441 . . . . 0.0 115.846 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 2' ' ' PRO . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.569 2.257 0 N-CA-C 115.549 1.326 . . . . 0.0 115.549 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 CA--C 1.569 2.253 0 N-CA-C 116.084 1.532 . . . . 0.0 116.084 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 115.844 1.44 . . . . 0.0 115.844 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 3' ' ' LEU . 67.8 Cg_endo . . . . . 0 CA--C 1.572 2.418 0 N-CA-C 116.068 1.526 . . . . 0.0 116.068 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 2' ' ' PRO . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 CA--C 1.571 2.327 0 N-CA-C 115.565 1.333 . . . . 0.0 115.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 N-CA-C 115.644 1.363 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 mtt85 -135.61 90.88 18.99 Favored Pre-proline 0 CA--C 1.563 1.478 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.99 -31.93 29.52 Favored 'Trans proline' 0 CA--C 1.57 2.317 0 C-N-CA 122.194 1.929 . . . . 0.0 115.519 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -79.93 39.81 0.44 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.04 -17.96 65.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 162.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.5 11.61 18.43 Favored 'General case' 0 CA--C 1.583 2.219 0 C-N-CA 125.496 1.519 . . . . 0.0 115.058 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -104.2 -56.56 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 126.2 1.8 . . . . 0.0 110.194 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -71.15 -33.61 70.21 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.69 81.24 2.48 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -68.09 -177.55 1.39 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 CA-C-N 122.338 1.871 . . . . 0.0 114.065 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -78.24 39.0 0.3 Allowed 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.07 20.33 4.78 Favored Glycine 0 CA--C 1.556 2.595 0 C-N-CA 125.099 1.333 . . . . 0.0 116.214 165.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -126.88 -75.8 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.859 1.329 . . . . 0.0 109.013 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 O-C-N 117.082 -3.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.105 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -116.93 146.91 38.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.41 -28.91 46.02 Favored 'Trans proline' 0 CA--C 1.573 2.445 0 C-N-CA 122.014 1.81 . . . . 0.0 116.512 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mp -80.35 40.58 0.5 Allowed 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 171.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -10.33 57.78 Favored 'General case' 0 CA--C 1.585 2.293 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 164.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.29 7.87 14.1 Favored 'General case' 0 CA--C 1.585 2.318 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.16 -56.42 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 126.178 1.791 . . . . 0.0 110.757 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -71.89 -30.93 65.92 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 79.57 2.41 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.943 0.897 . . . . 0.0 109.626 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -66.24 -178.9 1.24 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 CA-C-N 122.972 2.097 . . . . 0.0 114.51 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 35.4 0.1 Allowed 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.86 20.33 5.73 Favored Glycine 0 CA--C 1.556 2.608 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 165.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -124.93 -74.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 118.792 1.296 . . . . 0.0 109.971 177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 O-C-N 116.407 -3.933 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -112.87 93.64 25.5 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.84 -30.24 22.22 Favored 'Trans proline' 0 CA--C 1.572 2.381 0 CA-C-N 122.566 1.952 . . . . 0.0 115.417 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.99 40.87 0.49 Allowed 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 170.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -73.28 -8.76 57.22 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.39 10.0 12.59 Favored 'General case' 0 CA--C 1.582 2.192 0 C-N-CA 125.774 1.629 . . . . 0.0 114.489 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.18 -56.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 126.169 1.788 . . . . 0.0 109.875 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -70.93 -32.67 69.65 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.46 80.34 2.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 C-N-CA 123.811 0.844 . . . . 0.0 109.16 -175.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -67.72 -179.58 2.11 Favored 'Trans proline' 0 CA--C 1.558 1.678 0 CA-C-N 122.743 2.015 . . . . 0.0 114.4 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -73.7 38.4 0.1 Allowed 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.73 20.97 4.79 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 116.725 1.45 . . . . 0.0 116.725 164.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.78 -75.47 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.783 1.292 . . . . 0.0 109.44 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.529 0 O-C-N 117.179 -3.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 152.99 59.7 Favored Pre-proline 0 CA--C 1.572 1.815 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HG2' HD12 ' A' ' 3' ' ' LEU . 87.2 Cg_endo -64.53 -33.07 57.96 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 122.134 1.889 . . . . 0.0 115.846 169.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.41 HD12 ' HG2' ' A' ' 2' ' ' PRO . 2.1 mp -87.57 40.21 0.92 Allowed 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -10.74 60.25 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 164.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -117.67 12.2 13.91 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -104.83 -56.85 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 C-N-CA 126.406 1.882 . . . . 0.0 110.047 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -70.89 -33.84 70.98 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.84 80.33 2.84 Favored Pre-proline 0 CA--C 1.568 1.638 0 C-N-CA 123.704 0.801 . . . . 0.0 109.358 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.94 -179.36 2.08 Favored 'Trans proline' 0 CA--C 1.556 1.62 0 CA-C-N 122.841 2.051 . . . . 0.0 114.262 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 37.58 0.11 Allowed 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 167.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.9 21.55 4.96 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 165.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -127.34 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 118.752 1.276 . . . . 0.0 109.247 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.527 0 O-C-N 117.094 -3.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.018 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.26 58.03 15.36 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.33 -29.07 32.43 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 122.276 1.984 . . . . 0.0 115.549 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.86 38.43 0.39 Allowed 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.28 -10.42 58.88 Favored 'General case' 0 CA--C 1.581 2.152 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 163.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.35 2.69 14.03 Favored 'General case' 0 CA--C 1.585 2.289 0 C-N-CA 125.631 1.572 . . . . 0.0 114.966 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.07 -57.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 125.691 1.596 . . . . 0.0 110.929 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.19 -32.6 69.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.22 80.22 2.72 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.679 0.792 . . . . 0.0 109.282 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.11 -178.67 1.82 Allowed 'Trans proline' 0 CA--C 1.555 1.546 0 CA-C-N 122.903 2.072 . . . . 0.0 114.469 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -74.36 36.69 0.1 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 167.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.37 20.87 5.21 Favored Glycine 0 CA--C 1.554 2.49 0 N-CA-C 116.69 1.436 . . . . 0.0 116.69 165.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.01 -75.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 118.864 1.332 . . . . 0.0 109.254 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.525 0 O-C-N 117.084 -3.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.056 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -112.29 145.64 33.27 Favored Pre-proline 0 CA--C 1.569 1.704 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.09 -31.1 46.32 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.104 1.869 . . . . 0.0 116.084 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -81.68 40.38 0.59 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.22 -11.07 60.18 Favored 'General case' 0 CA--C 1.58 2.112 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 163.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.12 6.36 15.11 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.82 -57.45 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 126.119 1.768 . . . . 0.0 110.496 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -70.73 -33.62 71.03 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.98 79.45 3.27 Favored Pre-proline 0 CA--C 1.568 1.641 0 C-N-CA 123.43 0.692 . . . . 0.0 109.372 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.82 -178.69 1.72 Allowed 'Trans proline' 0 CA--C 1.554 1.523 0 CA-C-N 122.702 2.001 . . . . 0.0 114.474 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 36.14 0.1 Allowed 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.97 20.69 5.65 Favored Glycine 0 CA--C 1.553 2.448 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 164.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.78 -74.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 119.147 1.474 . . . . 0.0 110.352 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 O-C-N 117.108 -3.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.013 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -126.83 144.72 51.07 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 123.757 0.661 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.77 -32.08 47.35 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.05 1.833 . . . . 0.0 115.844 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.45 40.23 0.64 Allowed 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.27 -8.63 57.14 Favored 'General case' 0 CA--C 1.58 2.11 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 163.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 12.86 13.82 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.81 -57.33 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 C-N-CA 126.408 1.883 . . . . 0.0 109.966 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -70.39 -34.05 72.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.78 80.41 2.85 Favored Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 123.584 0.754 . . . . 0.0 109.568 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.19 -179.54 2.29 Favored 'Trans proline' 0 CA--C 1.558 1.722 0 CA-C-N 122.818 2.042 . . . . 0.0 114.44 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -74.22 39.55 0.12 Allowed 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.88 12.45 6.87 Favored Glycine 0 CA--C 1.553 2.453 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 163.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -122.87 -75.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.348 1.574 . . . . 0.0 109.796 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.572 0 O-C-N 117.003 -3.56 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.61 156.01 38.68 Favored Pre-proline 0 CA--C 1.573 1.84 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 3' ' ' LEU . 67.8 Cg_endo -65.39 -30.81 53.07 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.276 1.984 . . . . 0.0 116.068 166.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 2' ' ' PRO . 3.3 mp -81.7 40.02 0.57 Allowed 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -77.03 -17.46 58.78 Favored 'General case' 0 CA--C 1.582 2.175 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 167.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -105.29 5.79 32.27 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.4 -57.65 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.453 -1.404 . . . . 0.0 111.334 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -70.88 -29.73 65.9 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.04 79.39 2.56 Favored Pre-proline 0 CA--C 1.568 1.667 0 C-N-CA 123.91 0.884 . . . . 0.0 109.35 -175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -66.99 -179.24 1.63 Allowed 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 122.816 2.041 . . . . 0.0 114.37 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -76.59 41.42 0.26 Allowed 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 168.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.43 20.63 4.39 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 164.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -126.35 -75.54 0.58 Allowed 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.796 1.298 . . . . 0.0 109.444 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.113 -3.492 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 72.21 81.99 Favored Pre-proline 0 CA--C 1.569 1.688 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.11 -30.16 25.78 Favored 'Trans proline' 0 CA--C 1.571 2.327 0 C-N-CA 122.292 1.994 . . . . 0.0 115.565 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 mp -82.04 39.32 0.57 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.85 -12.26 59.96 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 166.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.0 t -109.75 7.67 24.34 Favored 'General case' 0 CA--C 1.58 2.12 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 172.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.6 -57.98 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.573 -1.329 . . . . 0.0 111.013 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -70.7 -30.68 67.31 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.91 79.23 2.95 Favored Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 123.65 0.78 . . . . 0.0 109.265 -174.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -67.59 -179.53 2.03 Favored 'Trans proline' 0 CA--C 1.555 1.572 0 CA-C-N 122.779 2.028 . . . . 0.0 114.445 176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.07 37.86 0.1 Allowed 'General case' 0 CA--C 1.581 2.167 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 166.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.97 21.05 5.01 Favored Glycine 0 CA--C 1.553 2.451 0 N-CA-C 116.716 1.446 . . . . 0.0 116.716 164.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.58 -75.58 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.888 1.344 . . . . 0.0 109.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 117.059 -3.525 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -137.27 80.24 34.59 Favored Pre-proline 0 CA--C 1.567 1.621 0 O-C-N 124.012 0.82 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -69.78 -29.51 23.64 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.444 2.096 . . . . 0.0 115.644 170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -79.97 42.09 0.54 Allowed 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.89 -12.16 59.46 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 166.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -110.16 6.79 23.01 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.94 -57.47 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.608 -1.307 . . . . 0.0 111.229 174.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -71.84 -30.29 65.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.38 79.43 2.77 Favored Pre-proline 0 CA--C 1.57 1.729 0 C-N-CA 123.875 0.87 . . . . 0.0 109.27 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.4 -179.64 2.01 Favored 'Trans proline' 0 CA--C 1.556 1.578 0 CA-C-N 122.873 2.062 . . . . 0.0 114.395 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 38.15 0.11 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 167.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 21.3 4.75 Favored Glycine 0 CA--C 1.556 2.603 0 N-CA-C 116.592 1.397 . . . . 0.0 116.592 165.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.33 -75.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.791 1.295 . . . . 0.0 109.323 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 O-C-N 117.07 -3.519 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_